Literature DB >> 25086313

Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula.

O Gardon1, L Faget1, P Chu Sin Chung1, A Matifas1, D Massotte1, B L Kieffer2.   

Abstract

The habenular complex, encompassing medial (MHb) and lateral (LHb) divisions, is a highly conserved epithalamic structure involved in the dorsal diencephalic conduction system (DDC). These brain nuclei regulate information flow between the limbic forebrain and the mid- and hindbrain, integrating cognitive with emotional and sensory processes. The MHb is also one of the strongest expression sites for mu opioid receptors (MORs), which mediate analgesic and rewarding properties of opiates. At present however, anatomical distribution and function of these receptors have been poorly studied in MHb pathways. Here we took advantage of a newly generated MOR-mcherry knock-in mouse line to characterize MOR expression sites in the DDC. MOR-mcherry fluorescent signal is weak in the LHb, but strong expression is visible in the MHb, fasciculus retroflexus (fr) and interpeduncular nucleus (IPN), indicating that MOR is mainly present in the MHb-IPN pathway. MOR-mcherry cell bodies are detected both in basolateral and apical parts of MHb, where the receptor co-localizes with cholinergic and substance P (SP) neurons, respectively, representing two main MHb neuronal populations. MOR-mcherry is expressed in most MHb-SP neurons, and is present in only a subpopulation of MHb-cholinergic neurons. Intense diffuse fluorescence detected in lateral and rostral parts of the IPN further suggests that MOR-mcherry is transported to terminals of these SP and cholinergic neurons. Finally, MOR-mcherry is present in septal regions projecting to the MHb, and in neurons of the central and intermediate IPN. Together, this study describes MOR expression in several compartments of the MHb-IPN circuitry. The remarkably high MOR density in the MHb-IPN pathway suggests that these receptors are in a unique position to mediate analgesic, autonomic and reward responses.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  acetylcholine; interpeduncular nucleus; knock-in mice; medial habenula; mu opioid receptor; substance P

Mesh:

Substances:

Year:  2014        PMID: 25086313      PMCID: PMC4164589          DOI: 10.1016/j.neuroscience.2014.07.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  88 in total

1.  Topographic commissural and descending projections of the habenula in the rat.

Authors:  Uhnoh Kim
Journal:  J Comp Neurol       Date:  2009-03-10       Impact factor: 3.215

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain.

Authors:  K Brinschwitz; A Dittgen; V I Madai; R Lommel; S Geisler; R W Veh
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

4.  Substance P receptor antagonist in lateral habenula improves rat depression-like behavior.

Authors:  Li-Min Yang; Lei Yu; Hui-Juan Jin; Hua Zhao
Journal:  Brain Res Bull       Date:  2013-10-21       Impact factor: 4.077

5.  Huntingtin distribution among striatal output neurons of normal rat brain.

Authors:  Francesca R Fusco; Alessandro Martorana; Zena De March; Maria Teresa Viscomi; Giuseppe Sancesario; Giorgio Bernardi
Journal:  Neurosci Lett       Date:  2003-03-13       Impact factor: 3.046

6.  The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta.

Authors:  Thomas C Jhou; Stefanie Geisler; Michela Marinelli; Beth A Degarmo; Daniel S Zahm
Journal:  J Comp Neurol       Date:  2009-04-20       Impact factor: 3.215

7.  Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear.

Authors:  Takashi Yamaguchi; Teruko Danjo; Ira Pastan; Takatoshi Hikida; Shigetada Nakanishi
Journal:  Neuron       Date:  2013-04-18       Impact factor: 17.173

8.  Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.

Authors:  Sharon R Grady; Milena Moretti; Michele Zoli; Michael J Marks; Alessio Zanardi; Luca Pucci; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

9.  Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission.

Authors:  Hirokazu Mizoguchi; Hirokazu Takagi; Chizuko Watanabe; Akihiko Yonezawa; Takumi Sato; Tsukasa Sakurada; Shinobu Sakurada
Journal:  Peptides       Date:  2014-01       Impact factor: 3.750

10.  Deficit in attachment behavior in mice lacking the mu-opioid receptor gene.

Authors:  Anna Moles; Brigitte L Kieffer; Francesca R D'Amato
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

View more
  28 in total

1.  Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome.

Authors:  Anna E Mechling; Tanzil Arefin; Hsu-Lei Lee; Thomas Bienert; Marco Reisert; Sami Ben Hamida; Emmanuel Darcq; Aliza Ehrlich; Claire Gaveriaux-Ruff; Maxime J Parent; Pedro Rosa-Neto; Jürgen Hennig; Dominik von Elverfeldt; Brigitte Lina Kieffer; Laura-Adela Harsan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

Review 2.  Circuits and functions of the lateral habenula in health and in disease.

Authors:  Hailan Hu; Yihui Cui; Yan Yang
Journal:  Nat Rev Neurosci       Date:  2020-04-08       Impact factor: 34.870

Review 3.  The Opioid Crisis and the Future of Addiction and Pain Therapeutics.

Authors:  Nathan P Coussens; G Sitta Sittampalam; Samantha G Jonson; Matthew D Hall; Heather E Gorby; Amir P Tamiz; Owen B McManus; Christian C Felder; Kurt Rasmussen
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

4.  Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking.

Authors:  Sami Ben Hamida; Laura-Joy Boulos; Michael McNicholas; Pauline Charbogne; Brigitte Lina Kieffer
Journal:  Addict Biol       Date:  2017-11-02       Impact factor: 4.280

5.  Specific Connectivity and Unique Molecular Identity of MET Receptor Tyrosine Kinase Expressing Serotonergic Neurons in the Caudal Dorsal Raphe Nuclei.

Authors:  Ryan J Kast; Hsiao-Huei Wu; Piper Williams; Patricia Gaspar; Pat Levitt
Journal:  ACS Chem Neurosci       Date:  2017-05-01       Impact factor: 4.418

6.  Specific connections of the interpeduncular subnuclei reveal distinct components of the habenulopeduncular pathway.

Authors:  Lely A Quina; Julie Harris; Hongkui Zeng; Eric E Turner
Journal:  J Comp Neurol       Date:  2017-05-30       Impact factor: 3.215

Review 7.  Translating the Habenula-From Rodents to Humans.

Authors:  Laura-Joy Boulos; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2016-06-07       Impact factor: 13.382

8.  Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.

Authors:  Aliza T Ehrlich; Meriem Semache; Julie Bailly; Stefan Wojcik; Tanzil M Arefin; Christine Colley; Christian Le Gouill; Florence Gross; Viktoriya Lukasheva; Mireille Hogue; Emmanuel Darcq; Laura-Adela Harsan; Michel Bouvier; Brigitte L Kieffer
Journal:  Brain Struct Funct       Date:  2017-11-06       Impact factor: 3.270

Review 9.  Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation.

Authors:  Catherine M Cahill; Wendy Walwyn; Anna M W Taylor; Amynah A A Pradhan; Christopher J Evans
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

Review 10.  The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models.

Authors:  Lola Welsch; Julie Bailly; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2019-08-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.